Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Variants of ADRA2A are associated with fasting glucose, blood pressure, body mass index and type 2 diabetes risk: meta-analysis of four prospective studies.

Diabetologia - 1 Jul 2011

Talmud P J, Cooper J A, Gaunt T, Holmes M V, Shah S, Palmen J, Drenos F, Shah T, Kumari M, Kivimaki M, Whittaker J, Lawlor D A, Day I N, Hingorani A D, Casas J P, Humphries S E

Abstract excerpt

AIMS/HYPOTHESIS: We quantified the effect of ADRA2A (encoding α-2 adrenergic receptor) variants on metabolic traits and type 2 diabetes risk, as reported in four studies. METHODS: Genotype data for ADRA2A single nucleotide polymorphisms (SNPs) rs553668 and rs10885122 were analysed in >17,000 individuals (1,307 type 2 diabetes cases) with regard to metabolic traits and type 2 diabetes risk. Two studies...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aged
Share to Blood Glucose
Share to Blood Pressure
Share to Body Mass Index
Share to Diabetes Mellitus, Type 2
Share to Fasting
Share to Polymorphism, Single Nucleotide
Share to Receptors, Adrenergic, alpha-2

Source

Open in PubMed Open full text

Identifiers

PMID: 21455730
DOI: 10.1007/s00125-011-2108-6
PMCID: PMC3110279

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Variants of ADRA2A are associated with fasting glucose, blood pressure, body mass index and type 2 diabetes risk: meta-analysis of four prospective studies.PMID 21455730Read ↗

Association of the ADRA2A polymorphisms with the risk of type 2 diabetes: a meta-analysis.Semantic proximity Read ↗

Genetic association of adrenergic receptor alpha 2A with obesity and type 2 diabetes.Semantic proximity Read ↗

Evaluation of the association between the ADRA2A genetic polymorphisms and type 2 diabetes in a Chinese Han population.Semantic proximity Read ↗

Variation in the α2A-adrenergic receptor gene and risk of gestational diabetes.Semantic proximity Read ↗

alpha2A-adrenergic receptors in the genetics, pathogenesis, and treatment of type 2 diabetes.Semantic proximity Read ↗

The rs10885122 polymorphism of the adrenoceptor alpha 2A (ADRA2A) gene in Euro-Brazilians with type 2 diabetes mellitus.Semantic proximity Read ↗

The ADRA2A rs553668 variant is associated with type 2 diabetes and five variants were associated at nominal significance levels in a population-based case-control study from Mexico City.Semantic proximity Read ↗

The rs553668 polymorphism of the ADRA2A gene predicts the worsening of fasting glucose values in a cohort of subjects without diabetes. A population-based study.Semantic proximity Read ↗

Variation in the α(2A) adrenoceptor gene and the effect of dexmedetomidine on plasma insulin and glucose.Semantic proximity Read ↗

Variations in the alpha2A-adrenergic receptor gene and their functional effects.Semantic proximity Read ↗

Genetic variations in the α(2A)-adrenoreceptor are associated with blood pressure response to the agonist dexmedetomidine.Semantic proximity Read ↗

Association between a deletion/insertion polymorphism in the alpha2B-adrenergic receptor gene and insulin secretion and Type 2 diabetes. The Finnish Diabetes Prevention Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.